Hydroxyapatite, Nano-Hydroxyapatite, and Fluoride: The Real Story Behind Your Toothpaste

Walk into any health food store, scroll through wellness influencer content, or browse the oral care aisle at your local retailer, and you will notice a growing trend: fluoride-free toothpaste. These products, many of which feature an ingredient called hydroxyapatite or nano-hydroxyapatite, are riding a wave of consumer demand for "cleaner," more natural personal care products. But here is the thing: the conversation around these ingredients is often incomplete, sometimes misleading, and rarely puts the full regulatory and scientific picture in front of you.

This article is not a warning against hydroxyapatite. It is not a hit piece on fluoride-free products. What it is, though, is an honest, thorough look at what hydroxyapatite and nano-hydroxyapatite actually are, where they came from, what the science says, why they remain outside the FDA's oral care monographs, and why fluoride's bad reputation is, frankly, undeserved.

The Mineral That Already Lives in Your Mouth

Before we talk about toothpaste formulations and regulatory frameworks, it helps to understand what hydroxyapatite actually is at a fundamental level.

Hydroxyapatite is a naturally occurring mineral from the calcium phosphate family. It is not some exotic lab-created compound; it is literally the primary building block of your teeth. Tooth enamel, the hardest substance in the human body, is composed of approximately 95% to 97% hydroxyapatite crystals, with the remaining portion made up of water, proteins, and trace minerals like strontium, magnesium, and fluoride. The dentin layer beneath the enamel is roughly 70% hydroxyapatite embedded in a collagen matrix.

So when you hear that hydroxyapatite toothpaste "remineralizes" your teeth, the concept is straightforward: it aims to replenish the same mineral your teeth are made of. Every day, your enamel goes through a tug-of-war between demineralization (acids pulling minerals out) and remineralization (saliva depositing minerals back in). When the loss side wins consistently, cavities form. The premise behind hydroxyapatite toothpaste is that you can tip that balance by directly supplying the mineral your enamel needs.

It is an elegant idea, and there is real science behind it. But the story of how hydroxyapatite ended up in your toothpaste is worth telling, because it did not start in a dentist's office. It started at NASA.

From Space Research to the Toothpaste Aisle: A Brief History

The modern story of hydroxyapatite in oral care begins in the late 1960s and early 1970s at NASA's Electronics Research Center in Cambridge, Massachusetts. Physicist Dr. Bernard Rubin was not looking for a dental ingredient at all. His team was studying crystal growth methods for semiconductors, a core need for space technology development. During this research, they noticed similarities between how crystals form and how minerals regenerate in bone and teeth.

This observation eventually led to a patented method for growing synthetic hydroxyapatite. NASA was not in the toothpaste business, but a Japanese entrepreneur named Shuji Sakuma, founder of Sangi Co., Ltd., was browsing a list of available NASA patents and took notice. In 1974, Sangi acquired the hydroxyapatite patent from NASA, and over the next several years, the company worked to implement Rubin's research into a viable consumer product.

In 1980, Sangi launched the world's first hydroxyapatite toothpaste in Japan. Clinical studies followed through the 1980s, including a one-year study involving over 1,000 children at Tokyo Medical and Dental University and a three-year study of 181 children at Asahi University. The three-year study reported caries reduction as high as 36% to 56%.

By 1993, Japan's Ministry of Health and Welfare officially approved Sangi's proprietary hydroxyapatite, which it branded "Medical Hydroxyapatite," as an active anti-caries agent. That approval recognized three specific effects: adsorption and removal of dental plaque, filling of microscopic defects on the tooth surface, and remineralization of sub-surface areas of mineral loss.

So hydroxyapatite has been used in toothpaste for over 40 years, with government recognition in Japan dating back more than three decades. It is not new, and it is not untested. It became available commercially in Europe in 2006 and in Canada in 2015. In 2003, Sangi further advanced the technology by reducing its nanoparticles from 100 nanometers to 50 nanometers, enhancing the ingredient's ability to penetrate below the surface of the enamel.

Nano-Hydroxyapatite vs. Micro-Hydroxyapatite: What is the Difference?

When you see "hydroxyapatite" on a toothpaste label, it is worth understanding that not all forms are the same. The two primary types on the market are nano-hydroxyapatite (nano-HA or nHA) and micro-hydroxyapatite (micro-HA).

Feature	Nano-Hydroxyapatite	Hydroxyapatite
Particle Size	20-100 nanometer	5-10 micron
Penetration	Deeper into enamel; fills micro-cracks	Stays primarily on the enamel surface
Biofilm Management	More effective due to particle size smaller than microorganisms​	Less effective in biofilm management​
Resemblance to Natural Enamel	Rod-shaped nanocrystalline particles resembling natural enamel crystals​	Significantly larger than organic enamel HAP​

Nano-hydroxyapatite particles are small enough to react with bacterial membranes and penetrate into the tiny defects that acid erosion creates on the enamel surface. Due to an increased surface area, nano-HA has a greater ability to bind to surfaces, which increases its effectiveness for remineralization and sensitivity reduction. Micro-HA, while still beneficial, does not penetrate as deeply or bind as effectively due to its larger particle size.

This distinction matters not just for effectiveness but also for safety discussions. The European Commission's Scientific Committee on Consumer Safety (SCCS) issued a final opinion in June 2025 finding that hydroxyapatite in nanoform is safe when used at concentrations up to 29.5% in toothpaste and up to 10% in mouthwash. The safety assessment found that HAP nano does not cause genetic mutations, cytotoxicity, or inflammation, and is not significantly taken up by cells. Most commercially available nano-hydroxyapatite toothpastes contain HAP concentrations of 10% or less.

What Does the Science Actually Say?

The research on hydroxyapatite is real, it is growing, and some of it is genuinely impressive.

A 2020 in vitro study published in Nature compared a fluoride-free oral care gel with 15% hydroxyapatite against a high-fluoride gel at 12,500 ppm. Both gels exhibited significantly higher mineral gain than artificial saliva alone, and there was no significant difference in remineralization between the two gels. The HAP gel achieved approximately 39% mineral gain compared to 41% for fluoride.

Even more compelling, a 2023 study published in Frontiers in Public Health conducted an 18-month double-blinded, randomized clinical trial comparing a fluoride-free hydroxyapatite toothpaste against a standard 1,450 ppm sodium fluoride toothpaste in adults. The results showed non-inferiority of the hydroxyapatite toothpaste: no increase in DMFS index (a standard measure of dental decay) was observed in 89.3% of subjects in the hydroxyapatite group compared to 87.4% in the fluoride group.

A 2019 study confirmed that 10% hydroxyapatite achieved comparable efficacy with 500 ppm fluoride in remineralizing initial caries and preventing demineralization. And a 2022 clinical study found that a hydroxyapatite-based toothpaste caused a greater reduction in hypersensitivity and pain values than conventional fluoride toothpaste.

One particularly interesting finding across multiple studies is that hydroxyapatite produces a more homogenous remineralization distributed throughout the entire thickness of the subsurface lesion, while fluoride tends to induce remineralization limited to the outer surface zone. That is a meaningful scientific observation, and it speaks to a genuine advantage that hydroxyapatite may hold in certain applications.

So Why Is Hydroxyapatite Not in the FDA Monographs?

Here is where the regulatory reality diverges from the marketing narrative.

In the United States, the FDA regulates toothpaste differently depending on what it contains. If a toothpaste contains fluoride and makes cavity-prevention claims, it is classified and regulated as an over-the-counter (OTC) drug. If it does not contain fluoride and makes no drug claims, it is classified as a cosmetic.

The FDA established the anticaries drug monograph, codified at 21 CFR Part 355, which was finalized on October 6, 1995, after a process extending over 25 years. This monograph established the conditions under which OTC anticaries drug products are generally recognized as safe and effective (GRASE). The monograph identifies three, and only three, approved active ingredients for cavity prevention in OTC dentifrices:

• Sodium fluoride - in gel or paste dosage forms containing 850 to 1,150 ppm theoretical total fluorine

• Sodium monofluorophosphate - at similar concentration ranges

• Stannous fluoride - at specified concentrations

That is it. Hydroxyapatite, nano-hydroxyapatite, or any form of calcium phosphate compound is nowhere in the monograph. This means that under current U.S. regulatory framework, a toothpaste containing hydroxyapatite as its primary active ingredient cannot legally make anticaries (cavity prevention) claims unless it goes through the New Drug Application (NDA) process, which requires two clinical caries trials to establish both effectiveness and safety.

The approval of new products with formulations outside the existing monograph demands this NDA pathway, and it is an expensive and time-consuming process. No company has yet pursued and obtained NDA approval for a hydroxyapatite-based anticaries product in the United States. This is a regulatory gap, not necessarily a scientific one, but it is a gap that has real implications for what companies can say about their products.

Adding to this, the American Dental Association (ADA) will not grant its Seal of Acceptance to any toothpaste that does not contain fluoride. The ADA considers fluoride content to be the most important aspect of a toothpaste evaluation, and all ADA-approved products must contain fluoride and meet strict standards for safety and effectiveness that exceed those required by law. Nano-hydroxyapatite toothpaste does not have the ADA's Seal of Acceptance.

It is also worth noting that in 2020, the CARES Act reformed and modernized the entire OTC monograph system in the United States. The legislation shifted the monograph process from notice-and-comment rulemaking to an administrative order system within FDA and expanded FDA resources through a user fee program. Under this reformed system, FDA has the authority to issue administrative orders that add, remove, or change GRASE conditions for an OTC drug monograph. This theoretically creates a pathway for new ingredients like hydroxyapatite to be evaluated for inclusion, but no such action has been initiated for HAP as of this writing.

Here is the bottom line on the regulatory picture: hydroxyapatite is approved for medical applications in the U.S. (bone grafts, implant coatings, dermal fillers), it is recognized as an anticaries agent in Japan since 1993, and it was recently confirmed safe for use in oral care products by the European Commission. But in the United States, it remains outside the anticaries monograph, which means it cannot make cavity-prevention claims as an OTC drug.

The Cultural Shift: Why "Fluoride-Free" Became a Selling Point

To understand why hydroxyapatite toothpaste has exploded in popularity in recent years, you have to understand the broader cultural shift happening in consumer products.

The natural toothpaste market was valued at approximately $3.1 billion in 2025 and is projected to reach $6.58 billion by 2035, growing at a compound annual growth rate of 7.9%. Natural and herbal variants now represent more than 70% of recent toothpaste product launches worldwide. The global toothpaste market as a whole, estimated at approximately $14.65 billion in 2025, is growing at a more modest 3.3% CAGR. The natural segment is dramatically outpacing the overall market.

This growth is driven by consumers increasingly seeking products with natural and herbal components, reflecting a broader movement toward ingredient transparency and health-conscious purchasing decisions. Brands that combine traditional or natural ingredients with contemporary science are experiencing significant success.

But let us be direct about what is also driving this trend: fear of fluoride.

Social media has played a substantial role in amplifying anti-fluoride messaging. A 2024 content analysis of fluoride-related posts on Instagram found that while 70.5% of posts with fluoride-related content were pro-fluoride, 29.5% were anti-fluoride. That might sound like the pro-fluoride side is winning, but the study found a high prevalence of posts containing false information about fluoride toxicity, claims of ineffectiveness for caries prevention, and outright conspiracy theories.

Particularly telling was a 2020 study by Lotto et al. referenced in the analysis, which found that a majority of anti-fluoride posts on Instagram were financially motivated, often promoting and advertising fluoride-free products and dentifrices containing natural ingredients. The researchers concluded that anti-fluoridation statements were influenced not only by ideological concerns but also by financial interests.

The "fluoride-free" label has become a marketing asset, and hydroxyapatite has become the beneficiary of that trend. There is nothing inherently wrong with that. Consumer demand drives innovation, and hydroxyapatite is a legitimate ingredient with real science behind it. But when the marketing around these products implicitly or explicitly suggests that fluoride is dangerous in the amounts found in toothpaste, that crosses a line from innovation into misinformation.

Fluoride's Reputation Problem: What the Numbers Actually Tell Us

Let us talk about fluoride toxicity, because this is where the conversation tends to go off the rails.

The probable toxic dose (PTD) for acute fluoride toxicity is 5 mg of fluoride per kilogram of body weight. Above this exposure level, medical intervention should be pursued. The lethal dose is estimated at 32 mg F/kg body weight for adults and 16 mg F/kg for children.

Now let us look at what is actually in your toothpaste and how much fluoride you are realistically exposed to.

A standard OTC fluoride toothpaste contains between 1,000 and 1,500 parts per million (ppm) of fluoride. The FDA's anticaries monograph permits sodium fluoride dentifrices containing 850 to 1,150 ppm theoretical total fluorine.

According to the NIH, estimated typical amounts of fluoride ingested daily from toothpaste are 0.1 mg to 0.25 mg for infants and children age 0 to 5 years, 0.2 to 0.3 mg for children age 6 to 12 years, and approximately 0.1 mg for adults. The optimal daily fluoride dose for adequate caries control is 0.05 to 0.07 mg F per kilogram of body weight.

To put this in real-world terms: for a child weighing 15 kg (about 33 pounds), reaching the probable toxic dose would require ingesting 75 mg of fluoride. That child would need to swallow approximately one-third of an entire tube of 1,000 ppm toothpaste in one sitting to reach that threshold. A single strip of toothpaste on a child-sized brush contains between 0.75 and 1.5 mg of fluoride.

For an adult weighing 70 kg (about 154 pounds), the probable toxic dose would be 350 mg of fluoride. You would need to eat roughly two and a half full tubes of toothpaste to reach that level. The typical adult ingests about 0.1 mg of fluoride per day from toothpaste. That is 3,500 times less than the toxic dose.

Are there legitimate concerns about fluoride? Sure. Dental fluorosis, a cosmetic condition involving enamel defects, can occur if children ingest too much fluoride during tooth development. Stronger fluoride toothpaste may increase the risk of fluorosis in developing teeth. This is why children's toothpaste is formulated at lower concentrations (often around 500 ppm) and why parents are advised to supervise brushing and use only a pea-sized amount.

But dental fluorosis from normal toothpaste use is primarily a cosmetic issue involving mild white spots, not a health crisis. And the solution is not to abandon fluoride altogether. It is proper supervision and age-appropriate dosing.

The Centers for Disease Control and Prevention has recognized community water fluoridation as one of the 10 great public health achievements of the 20th century, citing dramatic declines in both the prevalence and severity of tooth decay since fluoridation began in Grand Rapids, Michigan in 1945. The World Health Organization promotes fluoride toothpaste as a key strategy for dental caries prevention and recently added fluoride toothpaste to its model list of essential medicines.

Fluoride is not just effective. It is the gold standard for cavity prevention, endorsed by virtually every major health organization in the world. The fear surrounding it is disproportionate to the actual risk at recommended levels.

How Fluoride Actually Works: The Science

Understanding why fluoride has maintained its position as the gold standard requires understanding its mechanism of action, which is multifaceted and genuinely impressive from a biochemistry standpoint.

Fluoride works through four primary mechanisms:

1. Inhibiting demineralization. When fluoride is present, it reacts with enamel apatite crystals to form fluorapatite crystals, which are significantly more resistant to acid attack than hydroxyapatite crystals. Fluoride ions replace hydroxyl groups in the crystal lattice structure, and this substitution reduces the unit cell volume of the apatite, increasing dental enamel's hardness and acid resistance.

   
   

2. Enhancing remineralization. Fluoride speeds up the growth of new fluorapatite crystals by bringing calcium and phosphate ions together. When fluoride is present in oral fluids like saliva, fluorapatite forms during the remineralization process rather than hydroxyapatite, and this happens at an accelerated rate.

   
   

3. Antibacterial activity. Fluoride ions act as antibacterial agents and inhibitors of the bacterial enzyme enolase, which interferes with the production of phosphoenol pyruvate (PEP), an essential intermediate in the bacterial glycolytic pathway. In simpler terms, fluoride disrupts the bacteria's ability to produce the acids that cause cavities in the first place.

   
   

4. Reservoir effect. Fluoride ions retain on dental hard tissue, the oral mucosa, and dental plaque, creating a sustained protective reservoir that continues to decrease demineralization and enhance remineralization between brushings.

This is not a one-trick ingredient. Fluoride simultaneously makes your enamel harder, helps it rebuild faster, and fights the bacteria that cause damage. That combination of effects is why it has been the dominant anticaries agent for decades and why it remains the only ingredient class recognized in the FDA's anticaries monograph.

How Hydroxyapatite Works Differently

Hydroxyapatite takes a fundamentally different approach to protecting teeth. Rather than altering the mineral composition of enamel (as fluoride does by creating fluorapatite), hydroxyapatite works by directly replacing lost mineral with the same material enamel is made of.

When you brush with hydroxyapatite toothpaste, microscopic particles attach to the enamel surface, fill microscopic cracks and defects, smooth rough surfaces to reduce plaque buildup, and support remineralization by providing the exact minerals enamel needs. There is no chemical conversion or forced reaction. It is a like-for-like replacement, similar to patching a brick wall with the same type of brick.

This biomimetic approach, meaning it mimics natural biological processes, is one of the reasons hydroxyapatite appeals to consumers and scientists alike. The ingredient is biocompatible, non-toxic even if swallowed, and does not interfere with the oral microbiome. These are genuine advantages, particularly for populations like young children who are prone to swallowing toothpaste, or for individuals who experience sensitivity or adverse reactions to fluoride.

The research also suggests that hydroxyapatite may have a distinct advantage in how it remineralizes. Multiple studies have observed that while fluoride tends to remineralize primarily at the outer surface of a lesion, hydroxyapatite produces a more homogenous remineralization distributed throughout the entire depth of the subsurface lesion. This is a meaningful distinction that warrants further investigation.

The NAD Decision and What It Means for the Industry

For readers familiar with Howard Law's previous coverage of the Boka vs. Crest dispute, the regulatory landscape surrounding hydroxyapatite marketing claims has been brought into sharp focus.

In May 2025, the National Advertising Division (NAD) reviewed a challenge by Procter & Gamble against Essor Group (the company behind Boka toothpaste) regarding claims that Boka's nano-hydroxyapatite toothpaste "remineralizes" and "fortifies" teeth, whitens teeth, and provides prebiotic benefits. NAD found that Essor had submitted studies about nano-hydroxyapatite as an ingredient, but none of the studies actually tested Boka's finished product. NAD concluded that ingredient-level evidence is not sufficient to support product-specific marketing claims.

The National Advertising Review Board (NARB) upheld NAD's recommendations on appeal in July 2025. The appellate panel emphasized that claims about remineralization, whitening, and breath freshening need to be supported by studies on the actual formulated products, not just their individual ingredients. NARB also noted that neither the FDA nor the ADA has concluded that nano-hydroxyapatite remineralizes teeth.

This ruling raised the bar for the entire fluoride-free toothpaste industry. It does not mean hydroxyapatite products are ineffective. It means that the bold marketing claims some brands have been making may not be supported by the level of evidence that advertising regulations require. Companies selling hydroxyapatite toothpaste will need to invest in product-specific clinical trials rather than relying on general ingredient research.

Finding the Balance: A Practical Perspective

So where does all of this leave consumers, businesses, and the industry?

Hydroxyapatite and nano-hydroxyapatite are legitimate ingredients with over four decades of history and a growing body of scientific evidence supporting their use in oral care. They are safe, they are biocompatible, and they offer real benefits, particularly for remineralization and sensitivity reduction.

But they are not FDA-recognized anticaries agents in the United States. They are not included in the OTC anticaries monograph. They do not carry the ADA Seal of Acceptance. And the marketing claims made by many brands have outpaced the product-specific evidence available to support them.

Fluoride, on the other hand, has over 75 years of population-level evidence demonstrating its safety and effectiveness at recommended concentrations. It is endorsed by the CDC, WHO, ADA, and virtually every dental health organization worldwide. The amount of fluoride in over-the-counter toothpaste is regulated, controlled, and nowhere close to toxic levels for normal use.

The growing fear around fluoride, driven in large part by social media misinformation and financially motivated anti-fluoride marketing, has created a false equivalency between a well-established, heavily regulated ingredient and alternatives that, while promising, have not undergone the same level of regulatory scrutiny in the United States.

That said, the answer here is not to dismiss hydroxyapatite. The answer is to pursue proper regulatory pathways, invest in product-specific clinical evidence, and market these products honestly. The CARES Act's modernization of the OTC monograph system could theoretically provide a pathway for hydroxyapatite to be evaluated for monograph inclusion. Companies serious about positioning hydroxyapatite as a true alternative to fluoride should be advocating for and participating in that process.

What Businesses in the Oral Care Space Should Know

For companies manufacturing, marketing, or selling oral care products containing hydroxyapatite or nano-hydroxyapatite, the current regulatory and legal landscape demands careful attention:

• Classification matters. If your toothpaste does not contain fluoride and is not the subject of an approved NDA, it is classified as a cosmetic, not an OTC drug. This significantly limits what therapeutic or anticaries claims you can legally make.[21]

  
  

• Ingredient-level evidence is not enough. The NAD/NARB decisions in the Boka case made clear that marketing claims must be supported by studies on your actual finished product, not just the ingredient in isolation.

  
  

• The monograph is the gatekeeper. The FDA's anticaries monograph at 21 CFR Part 355 lists only fluoride compounds as approved active ingredients for cavity prevention. Until hydroxyapatite is added to this monograph or a company obtains NDA approval for a HAP-based product, cavity-prevention claims remain off-limits.

  
  

• The ADA Seal requires fluoride. The ADA will not grant its Seal of Acceptance to any toothpaste that does not contain fluoride. This remains a significant marketing barrier for fluoride-free products.

  
  

• International recognition does not equal U.S. approval. Japan's recognition of hydroxyapatite as an anticaries agent since 1993 and the EU's safety confirmation for nano-HAP are relevant data points, but they do not satisfy U.S. regulatory requirements.

The Wrap-up

Hydroxyapatite is a fascinating ingredient with a remarkable origin story, legitimate scientific backing, and genuine benefits for oral health. It has been around for over 40 years, and the research comparing it to fluoride continues to grow more robust. Neither consumers nor companies should be afraid of it.

But the rush to position hydroxyapatite as a replacement for fluoride has gotten ahead of the regulatory framework and, in some cases, ahead of the product-specific evidence. Fluoride remains the most extensively studied, most widely endorsed, and most rigorously regulated anticaries ingredient available. The amounts present in over-the-counter toothpaste are safe for normal use, and the fear surrounding fluoride is largely driven by misinformation rather than science.

The oral care industry is evolving, and hydroxyapatite will likely play an increasingly important role in that evolution. But evolution should be built on transparency, proper regulatory engagement, and honest marketing. Understanding the full picture, on both sides, is where it starts.

---

Howard Law is a business, regulatory and M&A law firm in the greater Charlotte, North Carolina area, with additional services in M&A advisory and business brokerage. Howard Law is a law firm based in the greater Charlotte, North Carolina area focused on business law, corporate law, regulatory law, mergers & acquisitions, M&A advisor and business brokerage. Handling all business matters from incorporation to acquisition as well as a comprehensive understanding in assisting through mergers and acquisition.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The information on this website is for general and informational purposes only and should not be interpreted to indicate a certain result will occur in your specific legal situation. Information on this website is not legal advice and does not create an attorney-client relationship. You should consult an attorney for advice regarding your individual situation. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.